{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:43:52Z","timestamp":1791233032456,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monocyte-derived macrophages are usually recruited and play pivotal roles in establishing an immunosuppressive tumor microenvironment, and the interplay between tumor cells and tumor-associated macrophages (TAMs) is crucial for tumor development. However, the detailed mechanisms remain largely unelucidated in certain aggressive human cancers, such as melanoma. Here, through miRNA sequencing analysis, we found the microRNA miR-708-5p was highly enriched in melanoma exosomes, which was dependent on SFRS1. Treatment by melanoma exosomes facilitated M2 polarization of macrophages, while the polarized macrophages in turn promoted melanoma progression and metastasis both in vitro and in vivo. Mechanistically, miR-708-5p directly targets FOXN3, a member of the fork head\/winged helix transcription factor family, and subsequently activates the PI3K\/AKT\/mTOR pathway in macrophages. Conversely, re-expression of FOXN3 in macrophages stably expressing miR-708-5p could reverse the impact on macrophages. In addition, downregulation of FOXN3 by miR-708-5p in macrophages reduced their phagocytic capacity and increased the secretion of IL-10 and TGF-\u03b2. Interestingly, we found that cellular retention of miR-708-5p could inhibit the proliferation and promote the apoptosis of melanoma cells, suggesting the necessity for secretion of this microRNA. In summary, our findings provide novel insights into the mechanism of melanoma-derived miR-708-5p in facilitating the formation of an immunosuppressive tumor microenvironment and indicate the potential of miR-708-5p and FOXN3 as therapeutic targets for the treatment of melanoma.<\/jats:p>","DOI":"10.1038\/s41419-026-08597-1","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:06:12Z","timestamp":1774325172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Melanoma exosomal miR-708-5p promotes macrophage M2 polarization and cancer metastasis"],"prefix":"10.1038","volume":"17","author":[{"given":"Meng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bincan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-2262","authenticated-orcid":false,"given":"Dan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"8597_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/cancers14010123","volume":"14","author":"OS Cherepakhin","year":"2021","unstructured":"Cherepakhin OS, Argenyi ZB, Moshiri AS. Genomic and transcriptomic underpinnings of melanoma genesis, progression, and metastasis. Cancers. 2021;14:123.","journal-title":"Cancers"},{"key":"8597_CR2","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/ijms26104882","volume":"26","author":"NBB Mohammed","year":"2025","unstructured":"Mohammed NBB, Shil RK, Dimitroff CJ. Melanoma glycome regulates the pro-oncogenic properties of extracellular galectin-3. Int J Mol Sci. 2025;26:4882.","journal-title":"Int J Mol Sci"},{"key":"8597_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105314","volume":"10","author":"J Braden","year":"2025","unstructured":"Braden J, Conway JW, Wilmott JS, Scolyer RA, Long GV, da Silva IP. Do BRAF-targeted therapies have a role in the era of immunotherapy? ESMO Open. 2025;10:105314.","journal-title":"ESMO Open"},{"key":"8597_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s11864-025-01340-6","volume":"26","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu J, Chang X, Yang X, Zhang X, Xiao W. A milestone in the shift from \u201cPassive Killing\u201d to \u201cActive immunomodulation\u201d in cancer treatment-progress in melanoma vaccine research. Curr Treat Options Oncol. 2025;26:688\u2013705.","journal-title":"Curr Treat Options Oncol"},{"key":"8597_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.cell.2014.04.016","volume":"157","author":"Y Okabe","year":"2014","unstructured":"Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell. 2014;157:832\u201344.","journal-title":"Cell"},{"key":"8597_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev. 2017;114:206\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"8597_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123\u201347.","journal-title":"Annu Rev Pathol"},{"key":"8597_CR8","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.ymthe.2022.01.046","volume":"30","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen Y, Ma L, Chen Y, Liu J, Guo Y, et al. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Mol Ther. 2022;30:3133\u201354.","journal-title":"Mol Ther"},{"key":"8597_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21:177.","journal-title":"Mol Cancer"},{"key":"8597_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","volume":"347","author":"I Kimiz-Gebologlu","year":"2022","unstructured":"Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Control Release. 2022;347:533\u201343.","journal-title":"J Control Release"},{"key":"8597_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","journal-title":"Science"},{"key":"8597_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.7150\/ijbs.53671","volume":"17","author":"H Wei","year":"2021","unstructured":"Wei H, Chen Q, Lin L, Sha C, Li T, Liu Y, et al. Regulation of exosome production and cargo sorting. Int J Biol Sci. 2021;17:163\u201377.","journal-title":"Int J Biol Sci"},{"key":"8597_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215823","volume":"548","author":"Q Tang","year":"2022","unstructured":"Tang Q, Yang S, He G, Zheng H, Zhang S, Liu J, et al. Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy. Cancer Lett. 2022;548:215823.","journal-title":"Cancer Lett"},{"key":"8597_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-019-0772-z","volume":"12","author":"X Tian","year":"2019","unstructured":"Tian X, Shen H, Li Z, Wang T, Wang S. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment. J Hematol Oncol. 2019;12:84.","journal-title":"J Hematol Oncol"},{"key":"8597_CR15","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","volume":"33","author":"R Isaac","year":"2021","unstructured":"Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021;33:1744\u201362.","journal-title":"Cell Metab"},{"key":"8597_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","volume":"30","author":"MA Mori","year":"2019","unstructured":"Mori MA, Ludwig RG, Garcia-Martin R, Brand\u00e3o BB, Kahn CR. Extracellular miRNAs: from biomarkers to mediators of physiology and disease. Cell Metab. 2019;30:656\u201373.","journal-title":"Cell Metab"},{"key":"8597_CR17","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"8597_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00281-018-0689-6","volume":"40","author":"MW Graner","year":"2018","unstructured":"Graner MW, Schnell S, Olin MR. Tumor-derived exosomes, microRNAs, and cancer immune suppression. Semin Immunopathol. 2018;40:505\u201315.","journal-title":"Semin Immunopathol"},{"key":"8597_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17:147.","journal-title":"Mol Cancer"},{"key":"8597_CR20","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.3390\/ijms24054593","volume":"24","author":"H Yu","year":"2023","unstructured":"Yu H, Pan J, Zheng S, Cai D, Luo A, Xia Z, et al. Hepatocellular carcinoma cell-derived exosomal miR-21-5p induces macrophage M2 polarization by targeting RhoB. Int J Mol Sci. 2023;24:4593.","journal-title":"Int J Mol Sci"},{"key":"8597_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109270","volume":"27","author":"S Huang","year":"2024","unstructured":"Huang S, Zhang P, Yin N, Xu Z, Liu X, Wu A, et al. Glioblastoma stem cell-derived exosomal miR-374b-3p promotes tumor angiogenesis and progression through inducing M2 macrophages polarization. iScience. 2024;27:109270.","journal-title":"iScience"},{"key":"8597_CR22","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.7150\/thno.51864","volume":"11","author":"J Xun","year":"2021","unstructured":"Xun J, Du L, Gao R, Shen L, Wang D, Kang L, et al. Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B. Theranostics. 2021;11:6847\u201359.","journal-title":"Theranostics"},{"key":"8597_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13046-024-03204-7","volume":"43","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li J, Yuan Y, Ju H, Liao H, Li M, et al. Exosomal miR-106a-5p from highly metastatic colorectal cancer cells drives liver metastasis by inducing macrophage M2 polarization in the tumor microenvironment. J Exp Clin Cancer Res. 2024;43:281.","journal-title":"J Exp Clin Cancer Res"},{"key":"8597_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41388-022-02547-9","volume":"42","author":"L Fattore","year":"2023","unstructured":"Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, et al. Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance. Oncogene. 2023;42:293\u2013307.","journal-title":"Oncogene"},{"key":"8597_CR25","doi-asserted-by":"publisher","first-page":"71292","DOI":"10.18632\/oncotarget.19772","volume":"8","author":"NJ Monteleone","year":"2017","unstructured":"Monteleone NJ, Lutz CS. miR-708-5p: a microRNA with emerging roles in cancer. Oncotarget. 2017;8:71292\u2013316.","journal-title":"Oncotarget"},{"key":"8597_CR26","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s44319-025-00410-y","volume":"26","author":"C Gilardi","year":"2025","unstructured":"Gilardi C, Martins HC, Levone BR, Bianco AL, Bicker S, Germain PL, et al. miR-708-5p is elevated in bipolar patients and can induce mood disorder-associated behavior in mice. EMBO Rep. 2025;26:2121\u201345.","journal-title":"EMBO Rep"},{"key":"8597_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487\u2013514.","journal-title":"Annu Rev Biochem"},{"key":"8597_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/1744666X.2024.2326626","volume":"20","author":"S Habib","year":"2024","unstructured":"Habib S, Osborn G, Willsmore Z, Chew MW, Jakubow S, Fitzpatrick A, et al. Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma. Expert Rev Clin Immunol. 2024;20:895\u2013911.","journal-title":"Expert Rev Clin Immunol"},{"key":"8597_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","volume":"107","author":"V Ambros","year":"2001","unstructured":"Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107:823\u20136.","journal-title":"Cell"},{"key":"8597_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-019-0264-y","volume":"20","author":"D Daassi","year":"2020","unstructured":"Daassi D, Mahoney KM, Freeman GJ. The importance of exosomal PDL1 in tumour immune evasion. Nat Rev Immunol. 2020;20:209\u201315.","journal-title":"Nat Rev Immunol"},{"key":"8597_CR31","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.4314\/tjpr.v21i11.8","volume":"21","author":"Y Han","year":"2023","unstructured":"Han Y, Wang S, Xia R, Chen J, Zhou B. FOXN3 attenuates doxorubicin resistance of bladder urothelial carcinoma via SIRT6\/PI3K\/AKT\/mTOR pathway. Trop J Pharm Res. 2023;21:2323\u201330.","journal-title":"Trop J Pharm Res"},{"key":"8597_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.101975","volume":"85","author":"R Gowda","year":"2020","unstructured":"Gowda R, Robertson BM, Iyer S, Barry J, Dinavahi SS, Robertson GP. The role of exosomes in metastasis and progression of melanoma. Cancer Treat Rev. 2020;85:101975.","journal-title":"Cancer Treat Rev"},{"key":"8597_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10555-021-09960-8","volume":"40","author":"HH Vandyck","year":"2021","unstructured":"Vandyck HH, Hillen LM, Bosisio FM, van den Oord J, Zur Hausen A, Winnepenninckx V. Rethinking the biology of metastatic melanoma: a holistic approach. Cancer Metastasis Rev. 2021;40:603\u201324.","journal-title":"Cancer Metastasis Rev"},{"key":"8597_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112832","volume":"149","author":"Y Tan","year":"2022","unstructured":"Tan Y, Tang F, Li J, Yu H, Wu M, Wu Y, et al. Tumor-derived exosomes: the emerging orchestrators in melanoma. Biomed Pharmacother. 2022;149:112832.","journal-title":"Biomed Pharmacother"},{"key":"8597_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32455","volume":"10","author":"C Shen","year":"2024","unstructured":"Shen C, Chen X, Lin Y, Yang Y. Hypoxia triggers cardiomyocyte apoptosis via regulating the m(6)A methylation-mediated LncMIAT\/miR-708-5p\/p53 axis. Heliyon. 2024;10:e32455.","journal-title":"Heliyon"},{"key":"8597_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/cvr\/cvy253","volume":"115","author":"M Calore","year":"2019","unstructured":"Calore M, Lorenzon A, Vitiello L, Poloni G, Khan MAF, Beffagna G, et al. A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signalling and miRNA dysregulation. Cardiovasc Res. 2019;115:739\u201351.","journal-title":"Cardiovasc Res"},{"key":"8597_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.identj.2022.08.001","volume":"73","author":"C Liang","year":"2023","unstructured":"Liang C, Li W, Huang Q, Wen Q. CircFKBP5 suppresses apoptosis and inflammation and promotes osteogenic differentiation. Int Dent J. 2023;73:377\u201386.","journal-title":"Int Dent J"},{"key":"8597_CR38","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.2147\/DDDT.S177128","volume":"12","author":"J Wu","year":"2018","unstructured":"Wu J, Fan W, Ma L, Geng X. miR-708-5p promotes fibroblast-like synoviocytes\u2019 cell apoptosis and ameliorates rheumatoid arthritis by the inhibition of Wnt3a\/\u03b2-catenin pathway. Drug Des Dev Ther. 2018;12:3439\u201347.","journal-title":"Drug Des Dev Ther"},{"key":"8597_CR39","first-page":"491","volume":"43","author":"T Feng","year":"2020","unstructured":"Feng T, Zhu Z, Jin Y, Wang H, Mao X, Liu D, et al. The microRNA\u2011708\u20115p\/ZEB1\/EMT axis mediates the metastatic potential of osteosarcoma. Oncol Rep. 2020;43:491\u2013502.","journal-title":"Oncol Rep"},{"key":"8597_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73929-w","volume":"10","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Qin X. MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K\/AKt pathway. Sci Rep. 2020;10:16729.","journal-title":"Sci Rep"},{"key":"8597_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12043","volume":"10","author":"F Fabbiano","year":"2020","unstructured":"Fabbiano F, Corsi J, Gurrieri E, Trevisan C, Notarangelo M, D\u2019Agostino VG. RNA packaging into extracellular vesicles: An orchestra of RNA-binding proteins? J Extracell Vesicles. 2020;10:e12043.","journal-title":"J Extracell Vesicles"},{"key":"8597_CR42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.semcancer.2022.03.018","volume":"86","author":"S Wang","year":"2022","unstructured":"Wang S, Sun Z, Lei Z, Zhang HT. RNA-binding proteins and cancer metastasis. Semin Cancer Biol. 2022;86:748\u201368.","journal-title":"Semin Cancer Biol"},{"key":"8597_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02190-w","volume":"21","author":"X Zhou","year":"2023","unstructured":"Zhou X, Hong Y, Liu Y, Wang L, Liu X, Li Y, et al. Intervening in hnRNPA2B1-mediated exosomal transfer of tumor-suppressive miR-184-3p for tumor microenvironment regulation and cancer therapy. J Nanobiotechnol. 2023;21:422.","journal-title":"J Nanobiotechnol"},{"key":"8597_CR44","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1038\/s41388-022-02457-w","volume":"41","author":"M Li","year":"2022","unstructured":"Li M, Xu H, Qi Y, Pan Z, Li B, Gao Z, et al. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression. Oncogene. 2022;41:4618\u201332.","journal-title":"Oncogene"},{"key":"8597_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"8597_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217772","volume":"625","author":"X Bai","year":"2025","unstructured":"Bai X, Guo YR, Zhao ZM, Li XY, Dai DQ, Zhang JK, et al. Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett. 2025;625:217772.","journal-title":"Cancer Lett"},{"key":"8597_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02888-5","volume":"22","author":"Z Xue","year":"2024","unstructured":"Xue Z, Liu J, Xing W, Mu F, Wu Y, Zhao J, et al. Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway. J Nanobiotechnol. 2024;22:628.","journal-title":"J Nanobiotechnol"},{"key":"8597_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01268-5","volume":"19","author":"C Ma","year":"2020","unstructured":"Ma C, Wang X, Yang F, Zang Y, Liu J, Wang X, et al. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224\/Smad4\/ADAR1 successive regulatory circuit. Mol Cancer. 2020;19:157.","journal-title":"Mol Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08597-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:01:58Z","timestamp":1774987318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08597-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8597"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08597-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}